In the present study we demonstrate for the first time a pro-survival role for GRK2 in two SHH subgroup medulloblastoma cell lines and GRK2-mediated mitigation of their cisplatin- and etoposide-induced apoptosis. Here, GRK2 is linked to medulloblastoma.